Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
986 Leser
Artikel bewerten:
(2)

Oil-Dri Corporation Of America: Amlan® International Welcomes New Director of Sales, North America

Finanznachrichten News

CHICAGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America and a global leader in mineral-based feed additives that optimize the intestinal health of poultry and livestock, announces the appointment of Chris Dyer as its Director of Sales, North America. In the role, Chris will work to advance Amlan's development strategies and present mineral-based solutions for customers in the U.S. and Canada. Chris' expertise in poultry production and animal health sales expands upon Amlan's recent focus on organizational growth and future sustained success in North American markets.

"We are impressed by Chris' strong track record of customer relationship development and the sales excellence he brings to Amlan. He will be key to the delivery of our highly researched mineral-based feed additives to producers in North America," said Heath Wessels, Vice President of Sales, The Americas. "The market is eagerly seeking natural products to maximize profitability in poultry and livestock, as their customers demand high-quality animal proteins. Chris' expertise in the North American market will help us showcase our mineral-based products' high value and demonstrate how natural feed additives can benefit their operations."

Chris has more than 35 years of experience in the poultry industry where he began his career as a hatchery and production manager. He led a team of regional account managers in the U.S. and Canada and was responsible for a multimillion-dollar program of medicated feed additives, biologicals and bio-device business. From there, Chris moved into a leadership role at a major poultry production business where he oversaw parent stock breeder sales in the U.S., Canada, Mexico and Central America.

"The Americas represent 41 percent of global broiler meat production and Amlan's mineral-based feed additives like Sorbiam continue to demonstrate efficacy in this growing marketplace," said Dr. Wade Robey, Vice President of Agriculture, Oil-Dri, and President, Amlan International. "Chris' experience as a business unit leader and his strong relationships align with our organizational efforts to ensure continued growth for Amlan in the North America region; we're excited to have him on the team."

Chris has numerous managerial certifications through the Strategic Account Management Association. He graduated from the University of Georgia with a B.S. in Agriculture.

Chris is pleased to be a part of the Amlan team that will be participating in the International Production and Processing Expo (IPPE) January 24-26, 2023, in Atlanta, Georgia. Chris looks forward to welcoming a global audience of animal production professionals and sharing more about Amlan's range of products with attendees, media and other exhibitors at Amlan's booth, B5453.

For more information on Amlan International, please visit www.amlan.com

Company Information

Amlan is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process its unique mineral for consumer and business-to-business markets. Oil-Dri Corporation of America doing business as "Amlan International" is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives across the world. Product availability may vary by country; associated claims do not constitute medical claims and may differ based on government requirements.

Reagan Culbertson
Media Contact
press@amlan.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/46b3e8d9-669b-46ca-8d74-8df533a6986f


© 2023 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.